11.04.2013 Views

michigan hypertension core curriculum - State of Michigan

michigan hypertension core curriculum - State of Michigan

michigan hypertension core curriculum - State of Michigan

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Definition<br />

Prevalence<br />

Clinical Features<br />

Diagnosis<br />

Types <strong>of</strong> Pathology<br />

Evaluation and Therapy<br />

98 Hypertension Core Curriculum<br />

Primary Aldosteronism<br />

Susan Steigerwalt, MD<br />

Pre test questions:<br />

1) What are the characteristics <strong>of</strong> hypertensive patients who should be screened for primary<br />

aldosteronism (PA)?<br />

2) What are the mechanisms for high BP in PA?<br />

3) What is the recommended screening test for PA? What is the role for confirmatory testing?<br />

Primary aldosteronism (PA) is a syndrome resulting from the autonomous hyper secretion <strong>of</strong><br />

aldosterone that is non suppressible by sodium loading. Aldosterone (aldo) is produced by a solitary<br />

adenoma or hyperplasia, or a combination <strong>of</strong> the two. The excess aldosterone results in cardiovascular<br />

hypertrophy and fibrosis as well as proteinuria most prominently when there is high dietary consumption<br />

<strong>of</strong> sodium. Other metabolic perturbations in the setting <strong>of</strong> high circulating aldosterone levels include<br />

an increase in plasminogen activator inhibitor 1 (PAI-1) associated with increased thrombosis and<br />

<strong>hypertension</strong> that may be, though not invariably, accompanied by hypokalemia, metabolic alkalosis,<br />

mild hypernatremia and glucose intolerance. Patient with PA have higher cardiovascular morbidity<br />

and mortality than age and sex-matched patients with primary <strong>hypertension</strong>. Thus, it is important<br />

to diagnose when it is present as there are specific treatments such as use <strong>of</strong> thiazide diuretics to<br />

control the aldosterone-induced volume expansion and aldosterone antagonists (spironolactone and<br />

epleronone) to specifically antagonize elevated circulating aldosterone levels and also the removal <strong>of</strong><br />

solitary adrenal glands when hypersecretion <strong>of</strong> aldosterone can be localized to one adrenal gland.<br />

Primary aldosteronism occurs in about 20% <strong>of</strong> patients with resistant <strong>hypertension</strong> (BP above goal<br />

despite therapeutic doses <strong>of</strong> three antihypertensive medications, including a diuretic or controlled BP<br />

on at least 4 BP lowering medications) and up to 10% <strong>of</strong> unselected hypertensive populations.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!